A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
NCT00089791 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 7808
Last updated 2022-11-08
Summary
This study will evaluate the effectiveness and safety of denosumab in treating women with Postmenopausal Osteoporosis.
Conditions
Interventions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-01
- Primary Completion
- 2008-06-17
- Completion
- 2008-06-17
More Related Trials
-
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
NCT00980174 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of Osteoporosis
NCT00523341 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
NCT00330460 ·Status: COMPLETED ·Phase: PHASE3
-
Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density
NCT00043186 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density
NCT00293813 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis
NCT01575834 ·Status: COMPLETED ·Phase: PHASE3
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Denosumab Safety Assessment in Multiple Observational Databases
NCT02520362 ·Status: COMPLETED
-
Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
NCT00091793 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Transitioning From Alendronate to Denosumab
NCT00377819 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density
NCT00325468 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis
NCT05278338 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects
NCT00306189 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index
NCT02435147 ·Status: COMPLETED
-
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
NCT06938152 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
NCT03822078 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)
NCT00885170 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab
NCT01457950 ·Status: COMPLETED ·Phase: PHASE3
-
Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
NCT03812367 ·Status: WITHDRAWN
-
Denosumab Fracture Intervention Randomized Placebo Controlled Trial in Japanese Patients With Osteoporosis
NCT00680953 ·Status: COMPLETED ·Phase: PHASE3
-
Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis
NCT00926380 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids
NCT01575873 ·Status: COMPLETED ·Phase: PHASE3
-
Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women
NCT01926158 ·Status: COMPLETED ·Phase: PHASE4
-
A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density
NCT00515463 ·Status: COMPLETED ·Phase: PHASE3
-
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis
NCT05419427 ·Status: RECRUITING ·Phase: PHASE3